Imexpharm Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	8,393,488	8,085,471	7,238,421	3,962,167	4,013,628	5,187,048
Market Cap Growth	14.98%	11.70%	82.69%	-1.28%	-22.62%	38.19%
Enterprise Value	8,204,972	8,062,671	7,072,195	3,840,834	3,828,514	5,172,206
Last Close Price	54500.00	52500.00	46549.81	25168.19	25127.46	31748.83
PE Ratio	27.57	26.56	24.33	14.26	21.83	29.89
Forward PE	22.86	19.33	19.33	19.33	19.33	19.33
PS Ratio	3.44	3.31	3.28	1.99	2.44	4.10
PB Ratio	3.64	3.51	3.32	1.90	2.12	2.89
P/TBV Ratio	3.76	3.62	3.43	1.97	2.20	3.01
P/FCF Ratio	307.54	296.26	60.57	-	14.37	28.50
P/OCF Ratio	154.94	149.26	33.47	-	10.60	22.08
EV/Sales Ratio	3.36	3.30	3.21	1.93	2.33	4.08
EV/EBITDA Ratio	14.51	14.26	13.62	8.28	10.73	17.56
EV/EBIT Ratio	17.74	17.43	17.04	10.08	12.91	22.10
EV/FCF Ratio	300.63	295.42	59.18	-	13.71	28.42
Debt / Equity Ratio	0.09	0.09	0.04	0.02	0.05	0.15
Debt / EBITDA Ratio	0.38	0.38	0.17	0.11	0.27	0.90
Debt / FCF Ratio	7.80	7.80	0.72	-	0.34	1.45
Net Debt / Equity Ratio	-0.08	-0.08	-0.10	-0.07	-0.16	-0.07
Net Debt / EBITDA Ratio	-0.33	-0.33	-0.42	-0.32	-0.83	-0.41
Net Debt / FCF Ratio	-6.91	-6.91	-1.82	1.45	-1.06	-0.66
Asset Turnover	0.92	0.92	0.90	0.85	0.72	0.58
Inventory Turnover	1.85	1.85	1.68	1.78	1.78	1.46
Quick Ratio	2.05	2.05	2.00	1.49	1.62	1.56
Current Ratio	4.05	4.05	4.38	3.92	2.89	2.88
Return on Equity (ROE)	15.55%	15.55%	15.04%	15.06%	12.12%	10.73%
Return on Assets (ROA)	10.93%	10.93%	10.60%	10.20%	8.11%	6.66%
Return on Invested Capital (ROIC)	16.85%	17.72%	16.90%	17.12%	13.89%	10.94%
Return on Capital Employed (ROCE)	19.20%	19.20%	19.00%	18.30%	15.70%	12.40%
Earnings Yield	3.63%	4.32%	4.43%	7.56%	5.57%	3.65%
FCF Yield	0.33%	0.34%	1.65%	-2.60%	6.96%	3.51%
Dividend Yield	0.92%	-	1.07%	1.81%	1.72%	2.04%
Payout Ratio	22.06%	22.05%	21.82%	22.26%	44.74%	52.89%
Buyback Yield / Dilution	-	-	-	0.00%	0.00%	-2.92%
Total Shareholder Return	0.92%	-	1.07%	1.81%	1.72%	-0.87%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.